| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 124, 1064-1076, Copyright © 1989 by Endocrine Society
ARTICLES |
T Alexandrides, AC Moses and RJ Smith
Joslin Diabetes Center, Brigham and Women's Hospital, Boston, Massachusetts.
Insulin and insulin-like growth factors (IGFs) stimulate responses in skeletal muscle that include effects on carbohydrate and fat metabolism, protein turnover, growth, and differentiation. To gain insight into the relative importance of insulin and IGFs at different stages of development, the expression of their specific receptors was evaluated in skeletal muscle of rats from the late fetal period through 40 weeks of age. Distinct receptors for insulin. IGF-I and IGF-II are present in crude membrane preparations and wheat germ agglutinin- purified extracts of hindlimb muscle from rats at all ages, but each of the three receptors follows a different pattern of expression during development. There is a marked predominance of IGF-II receptors in fetal muscle (80- and 55-fold more abundant than insulin and IGF-I receptors, respectively) and a rapid decline in IGF-II receptors in early postnatal life. IGF-I receptors are more abundant than insulin receptors in the term fetus, remain constant in number until approximately 4 weeks of age, and then gradually decline to adult levels. Insulin receptor number rises 2- to 3-fold postnatally, peaks at approximately 4 weeks, and decreases to levels in the adult that are slightly lower than those in the term fetus. Although binding affinities and receptor specificity did not change during development, the relatively large number of IGF-II receptors in the fetus resulted in significant binding of IGF-I to receptors for both IGF-II and IGF-I. There was a modest increase in apparent mol wt of all three receptor types during development, suggesting a change in a common pathway, such as posttranslational glycosylation. The marked changes in number and distinct patterns of expression of the insulin, IGF-I, and IGF-II receptors in muscle during development are consistent with evolving functions of the three hormones determined by alterations in both receptor number and hormone concentrations.
This article has been cited by other articles:
![]() |
A. Urayama, J. H. Grubb, W. S. Sly, and W. A. Banks Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier PNAS, August 24, 2004; 101(34): 12658 - 12663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suryawan, H. V. Nguyen, R. A. Orellana, J. A. Bush, and T. A. Davis Insulin/Insulin-Like Growth Factor-I Hybrid Receptor Abundance Decreases with Development in Suckling Pigs J. Nutr., September 1, 2003; 133(9): 2783 - 2787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suryawan, H. V. Nguyen, J. A. Bush, and T. A. Davis Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E908 - E915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Blondin, P. W. Farin, A. E. Crosier, J. E. Alexander, and C. E. Farin In Vitro Production of Embryos Alters Levels of Insulin-like Growth Factor-II Messenger Ribonucleic Acid in Bovine Fetuses 63 Days After Transfer Biol Reprod, February 1, 2000; 62(2): 384 - 389. [Abstract] [Full Text] |
||||
![]() |
F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo, A. Costantino, I. D. Goldfine, A. Belfiore, and R. Vigneri Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells Mol. Cell. Biol., May 1, 1999; 19(5): 3278 - 3288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |